Pharmafile Logo
Pharmafocus logo
Advanced Search
Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011
Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …

News

Teva surges ahead

February 9, 2011
Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical

Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …

News

Dr Matthias joins Noxxon Pharma

February 9, 2011
Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development

Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …

Appointment
Advanced melanoma

Melanoma: intense competition to be the next milestone treatment

February 9, 2011
Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab

A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …

Feature

AZ-Targacept depression candidate moves into phase IIb

February 9, 2011
Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder

AstraZeneca and Targacept have begun a phase IIb trial of TC-5214 as a ‘switch’ monotherapy for patients with depression. The …

News

Early diagnosis key to UK cancer ambition

February 8, 2011
Cancer, NHS, NICE

A series of quality standards on cancer care is to be drawn up by NICE as part of a new …

Feature

Genzyme to divest pharma intermediates business

February 8, 2011
Manufacturing and Production Cerezyme, Corden Pharma Switzerland, Corden Pharma group, Genzyme, International Chemical Investors Group, Sekisui Chemical Co, imiglucerase

Genzyme has agreed to sell off its pharmaceutical intermediates business to International Chemical Investors Group, a holding company which has …

News

Pharmaceutical facility news in brief

February 8, 2011
Manufacturing and Production Baxter International, Famar, Lannett, Qatar Pharma, Sanofi-Aventis, Takeda Pharmaceutical Co

A round-up of news involving manufacturing facilities includes updates from Takeda, Famar/Sanofi, Qatar Pharma, Lannett and Baxter. Takeda Pharmaceutical Co …

News

Roche eyes ovarian cancer expansion for Avastin

February 8, 2011
Sales and Marketing Cancer, Roche, avastin, bevacizumab, ovarian cancer

Roche has submitted an EU marketing authorisation for Avastin for the treatment of ovarian cancer and plans to file the …

News

Stabilitech appoints new commercial director

February 8, 2011
Manufacturing and Production Donna Hackett, Stabilitch, appointment, manufacturing and production

Donna Hackett joins stabilisation company Stabilitch as commercial director. She has 20 years pharma experience, most recently at pre-clinical, clinical …

Appointment

Teva plant in Israel cited by FDA, expands in Americas

February 8, 2011
Manufacturing and Production Corporacion Infarmasa, FDA, Peru, Teva, Teva Pharmaceutical, generics, generics manufacturing, manufacturing compliance

A manufacturing facility in Jerusalem operated by Teva Pharmaceutical failed to pass muster in an FDA inspection, prompting a warning …

News

Avecia Biotech sold to Nitto Denko

February 8, 2011
Manufacturing and Production Avecia, Avecia Biologics, Avecia Biotechnology, Nitto Denko

Avecia Biotechnology, which focuses mainly on the development and manufacturing of oligonuceotide medicines, has been acquired by Japanese firm Nitto …

News
AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011
Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …

News

Merck KGaA appoints Frederic Wohlwend

February 7, 2011
Sales and Marketing Frederic Wohlwend, Merck KGaA, appointment, sales and marketing

Frederic Wohlwend has been promoted to chief information officer at Merck KGaA with effect from 1 April. He succeeds Kai …

Appointment
Pfizer research Sandwich, Kent

Pressure mounts on Pfizer and government over UK R&D closure

February 7, 2011
Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee

The political fallout over Pfizer’s decision to close its Kent R&D base continues apace, with the House of Commons to …

News

Late-stage blow to AstraZeneca’s prostate cancer drug

February 7, 2011
Research and Development AstraZeneca, Cancer, prostate cancer, zibotentan

A late-stage trial of AstraZeneca’s oral prostate cancer drug zibotentan has been halted after it failed to meet its primary …

News
Roche's Avastin (bevacizumab)

Survey shows doctors support FDA Avastin decision

February 7, 2011
Sales and Marketing FDA, Roche, Sermo, avastin, bevacizumab

A survey of US doctors suggests that a majority support the FDA’s decision to take away Avastin’s licence for use …

News

GSK profits slump amid ongoing Avandia woes

February 7, 2011
Sales and Marketing 2010 pharma results, Avandia, GSK, GlaxoSmithKline

GlaxoSmithKline’s ongoing woes with diabetes drug Avandia hit profits in 2010. Profits after tax plummeted 56% to £3 billion for …

News

Merck dipped into the red as 2010 ended

February 4, 2011
Sales and Marketing 2010 pharma results, Merck & Co

Merck & Co made a $531 million loss in the final quarter of 2010 – down from a profit of …

News
Merck Serono cancer disease awareness campaign

Digital Pharma: Merck Serono launches campaign for cancer carers

February 4, 2011
Medical Communications Cancer, Digital Pharma blog, Merck Serono, disease awareness campaigns, lung cancer

Merck Serono has launched an educational lung cancer website for the ‘people behind the patients’ in Europe. Unveiled to coincide …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026